REPRESENTING INJURED VICTIMS OF DRUG-ELUTING HEART STENTS
Drug-eluting stents are drug-coated cylindrical-shaped wire mesh devices that are used to prop open arteries. Drug-eluting stents were approved by the FDA in 2003 and hailed as an innovative solution to the problem of clogged arteries. Their predecessors, bare metal mesh stents, also worked by propping up clogged arteries, but failed once scar tissue formed around the stents and caused the arteries to become re-clogged. The drug-eluting stents work by propping open the clogged artery and then slowly releasing medication that works to keep scar tissue from forming around the device.
Unfortunately, these innovative medical devices are not without their risks. The drug that keeps the arteries from re-clogging can cause serious side-effects including blood clots, heart attack, and death. The American College of Cardiology estimates that 2,000 people die each year due to complications from drug-eluting stents.
STUDY REVIEW SHOWS NO BENEFIT OF STENTS IN TREATMENT OF CORONARY ARTERY DISEASE
A review of randomized, controlled drug trials revealed that using a drug coated stent to treat stable coronary artery disease provided no additional benefit over standard medical care. Usage of beta blockers, ACE inhibitors, statins, and aspirin was found to be just as effective as a drug-eluting stent. An author of the review said that more than half of patients were treated with a stent before attempting a traditional drug treatment.
According to the New York Times, theories suggest that the line of treatment can also reduce mortality by improving blood flow, yet the researchers found no evidence to support these thoughts.
DRUG-ELUTING STENTS ON THE MARKET
There are many different drug-eluting stents currently on the market.
- Boston Scientific Corporation — PROMUS Element Stent
- Medtronic — Resolute Integrity Stent
- Abbot Laboratories — XIENCE Alpine Stent
- Biosensors International Group Ltd. — BioMatrix Stent
Johnson & Johnson’s Cordis Corporation removed its Cypher stent from the market in 2011 after hundreds of reports of blood clots and at least 60 deaths in patients who received the stent. The FDA also received reports of hypersensitivity reactions, including rashes, hives, itching, fever, and respiratory issues.
HARMED BY A DRUG-ELUTING STENT? CONTACT THOMAS J. HENRY IMMEDIATELY
If you or a loved one suffered an injury or died after having a drug-eluting stent implanted, you may be entitled to compensation. At Thomas J. Henry, our experienced defective medical device attorneys will take immediate action on your case to hold the manufacturer accountable for your injuries or loss. Contact us today for a free legal consultation.